Evaluating Co-Expression of EZH2 and MYC in Mantle Cell Lymphoma

被引:0
|
作者
Patel, Sanjay
Eikhoff, Jens
Shaw, Gene
Kahl, Brad
Yang, David
机构
[1] Univ Wisconsin, Madison, WI USA
[2] Marshfield Clin Fdn Med Res & Educ, Marshfield, WI USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1478
引用
收藏
页码:371A / 371A
页数:1
相关论文
共 50 条
  • [11] Upregulation of the polycomb group protein EZH2 in proliferating, cultured mantle cell lymphoma.
    Visser, HPJ
    Gunster, MJ
    Otte, AP
    Manders, EMM
    Raaphorst, FM
    Willemze, R
    Kluin-Nelemans, HC
    BLOOD, 2000, 96 (11) : 697A - 697A
  • [12] LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2
    Xin Wang
    Lalit Sehgal
    Neeraj Jain
    Tamer Khashab
    Rohit Mathur
    Felipe Samaniego
    Journal of Translational Medicine, 14
  • [13] Co-expression of Bmi1 and EZH2 as an independent poor prognostic factor in esophageal squamous cell carcinoma
    Ha, Sang Yun
    Kim, Seok-Hyung
    PATHOLOGY RESEARCH AND PRACTICE, 2012, 208 (08) : 462 - 469
  • [14] Epigenetic silencing of miR-26A1 in chronic lymphocytic leukemia and mantle cell lymphoma: Impact on EZH2 expression
    Kopparapu, Pradeep Kumar
    Bhoi, Sujata
    Mansouri, Larry
    Arabanian, Laleh S.
    Plevova, Karla
    Pospisilova, Sarka
    Wasik, Agata M.
    Croci, Giorgio Alberto
    Sander, Birgitta
    Paulli, Marco
    Rosenquist, Richard
    Kanduri, Meena
    EPIGENETICS, 2016, 11 (05) : 335 - 343
  • [15] Immunohistochemical evaluation of MYC expression in mantle cell lymphoma
    Oberley, Matthew J.
    Rajguru, Saurabh A.
    Zhang, Chong
    Kim, KyungMann
    Shaw, Gene R.
    Grindle, Kreg M.
    Kahl, Brad S.
    Kanugh, Craig
    Laffin, Jennifer
    Yang, David T.
    HISTOPATHOLOGY, 2013, 63 (04) : 499 - 508
  • [16] TP53 mutation is frequent in mantle cell lymphoma with EZH2 expression and have dismal outcome when both are present
    Kim, Do Hwan
    Siddiqui, Saima
    Jain, Preetesh
    Wang, Michael
    Thakral, Beenu
    Li, Shaoying
    Miranda, Roberto
    Vega, Francisco
    Medeiros, L. Jeffrey
    Ok, Chi Young
    HUMAN PATHOLOGY, 2024, 146 : 1 - 7
  • [17] Inverse co-expression of EZH2 and acetylated H3K27 in prostatic tissue
    Puzyrenko, Andrii
    Kumar, Suresh N.
    Pantazis, Cooley G.
    Iczkowski, Kenneth A.
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2022, 59
  • [18] EZH2 MUTATION IN FOLLICULAR LYMPHOMA
    O' Riain, C.
    Smith, P.
    Clear, A.
    Wrench, D.
    Gupta, M.
    Boedoer, C.
    Matolcsy, A.
    Calaminici, M.
    Ouentmeier, H.
    Drexler, H.
    Young, B.
    Gribben, J.
    Lister, A.
    Fitzgibbon, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 167 - 167
  • [19] Targeting mir101/EZH2/NFkb axis by FGFR1 inhibitor in mantle cell lymphoma
    Sehgal, Lalit
    Jain, Neeraj
    Khashab, Tamer
    Wang, Xin
    Neelapu, Sattva
    Samaniego, Felipe
    CANCER RESEARCH, 2016, 76
  • [20] Next-generation Sequencing Revealed Frequent TP53 mutation in Mantle Cell Lymphoma with Enhancer of Zeste Homolog 2 (EZH2) Expression
    Kim, Do Hwan
    Li, Shaoying
    Kanagal-Shamanna, Rashmi
    Miranda, Roberto
    Vega-Vazquez, Francisco
    Medeiros, L. Jeffrey
    Ok, Chi Young
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 966 - 967